Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.
We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.
We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon.
Understanding And Reducing Risk Of Breast Cancer Recurrence Phentermine Vs Benzphetamine
Location
Lisbon
Publication date
Reference
News release
In United States Publish Post Time: 2025-07-29
Learn how testing may help you make more informed treatment decisions, predict your personal risk of recurrence, and hear about treatments that may be available to reduce risk. We will also talk about changes you can make right away to help improve your quality of life and lower risk of recurrence.
This is the first session of the two-part series "Navigating risk of recurrence after an early-stage breast cancer diagnosis". A breast cancer diagnosis impacts your physical and emotional well-being and makes the future seem uncertain. This two-part webinar series will empower you to learn about your risk of recurrence, share what you can do to reduce your risk, and learn coping strategies to manage fear of recurrence.
To read more about the series visit
Understanding And Reducing Risk Of Breast Cancer Recurrence For Country: United States. City: Detroit, Downey, Lancaster, Orlando, Pembroke Pines
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:
Kathy Robertson
Principal manager
Media relations and corporate communication